PEGylated liposome-encapsulated rhenium-188 radiopharmaceutical inhibits proliferation and epithelial–mesenchymal transition of human head and neck cancer cells in vivo with repeated therapy

Human head and neck squamous cell carcinoma (HNSCC) is usually treated with chemoradiotherapy, but the therapeutic efficacy could be hampered by intrinsic radioresistance and early relapse. Repeated administrations of rhenium-188 ((188)Re)-conjugated radiopharmaceutical has been reported to escalate...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chun-Yuan, Chen, Chao-Cheng, Lin, Liang-Ting, Chang, Chih-Hsien, Chen, Liang-Cheng, Wang, Hsin-Ell, Lee, Te-Wei, Lee, Yi-Jang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208374/
https://www.ncbi.nlm.nih.gov/pubmed/30393570
http://dx.doi.org/10.1038/s41420-018-0116-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208374/
https://www.ncbi.nlm.nih.gov/pubmed/30393570
http://dx.doi.org/10.1038/s41420-018-0116-8

Ejemplares similares